Position in KRYS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$79,165
New position
Shares Held
213
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#332
of 419 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Concord Wealth Partners holds $158,287 across 14 Biotechnology names. KRYS ranks #1 (50.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
This page
|
213 | $79,165 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
200 | $60,206 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
200 | $7,422 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
66 | $5,165 | |
| 5 | TECH |
BIO-TECHNE Corp
|
44 | $3,108 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
60 | $1,044 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
11 | $599 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
5 | $585 |
All Filings in KRYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,165 | 213 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||